The first 100 bases of many genes show excess mutations, revealing a major genomic weak spot that shapes disease risk and ...
Cedars-Sinai scientists have created a new experimental drug called TY1 that helps the body repair damaged DNA and restore ...
Breaking down 'Pluribus' on Apple TV, from the Joining’s origin to Carol’s immunity and the hive mind’s darkest rules.
We have long struggled to determine how the first living organisms on Earth came together. Now, surprising evidence hints ...
ExtremeTech on MSN
Scientists Successfully Extract 40,000-Year-Old RNA From Woolly Mammoth
Now, scientists have published incredible findings from a Siberian mammoth they've named Yuka, revealing that they've found mostly intact RNA that can be dated to around 40,000 years old. It's an ...
The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is ...
Eight month follow-up data published in Communications Medicine, a Nature portfolio journal Full clinical dataset supports further development of RBI-4000 as a next generation vaccine approach for ...
We preselected all newsletters you had before unsubscribing.
People are still debating whether the mRNA from COVID-19 vaccines remains in the body longer than it should. Some say it lingers and causes harm, others say that idea just doesn’t hold up. A new ...
Novo Nordisk agreed to collaborate with Replicate Biosciences to develop potential new treatments for obesity, type 2 diabetes and other cardiometabolic diseases, as it grapples with mounting ...
Aug 28 (Reuters) - Replicate Bioscience will partner with Novo Nordisk (NOVOb.CO), opens new tab to develop treatments using self-replicating RNA technology for obesity, type 2 diabetes and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback